awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40971388-A9293A70-C696-47CC-A941-1C45F06E158B
Q40971388-A9293A70-C696-47CC-A941-1C45F06E158B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40971388-A9293A70-C696-47CC-A941-1C45F06E158B
A Phase II Study of Coltuximab Ravtansine (SAR3419) Monotherapy in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia.
P2860
Q40971388-A9293A70-C696-47CC-A941-1C45F06E158B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40971388-A9293A70-C696-47CC-A941-1C45F06E158B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
258b1ad816220b359a3e6e79d7a36cf8812e6449
P2860
SAR3419: an anti-CD19-Maytansinoid Immunoconjugate for the treatment of B-cell malignancies.